Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study.

Summary

# Editorial Summary: Equine Grass Sickness and *Clostridium botulinum* Antibody Status Equine grass sickness remains a devastating condition with poorly understood causes, though recent evidence points toward *Clostridium botulinum* involvement. This matched case-control study investigated whether affected horses had different antibody responses to *C. botulinum* compared with healthy controls, whilst accounting for critical confounders including age, season and premises—factors that could otherwise distort findings. Results demonstrated significantly lower anti-*C. botulinum* antibody titres in grass sickness cases than matched controls, suggesting either inadequate prior exposure to the organism or impaired immune response in affected animals. These findings strengthen the epidemiological case for *C. botulinum*'s role in disease aetiology and have important implications: they hint at possible prevention strategies through targeted exposure or immunisation protocols, and suggest that horses with naturally low antibody levels to this pathogen may represent a susceptible population. For practitioners, this reinforces the need to consider immune status and *Clostridium* exposure history when counselling on grass sickness risk, particularly in at-risk grazing environments.

Read the full abstract on PubMed

Key Findings

• •Equine grass sickness is associated with low antibody levels to Clostridium botulinum
• •Study design controlled for potential confounders including age, time of year, and premises
• •Findings support previous investigations linking C. botulinum to grass sickness aetiology

Conditions Studied